Key facts
- This page summarizes Darcy G. Mott's Form 4 filing for HEALTHEQUITY, INC. (HQY).
- 4 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 21 Sep 2021, 14:06.
Darcy G. Mott - 20 Sep 2021 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)
- Reporting relationship
- Special Advisor
- Issuer ticker
- HQY
- Reported as of
- 20 Sep 2021
- Net transaction value
- -$232,344
- SEC form
- 4
- Accepted by SEC
- 21 Sep 2021, 14:06:46 UTC
- Prior SEC filing
- 24 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Darcy G. Mott
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Darcy G. Mott filed Form 4 for HEALTHEQUITY, INC. (HQY) on 21 Sep 2021.
Change
- Previous filing in this sequence was filed on 24 Aug 2021.
- Current net transaction value: -$232,344.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HQY
transaction
Common Stock
Options Exercise
- Transaction value
- $140,000
- Shares
- +10,000
- Change %
- +11%
- Price
- $14.00*
- Shares after
- 97,052
- Date
- 20 Sep 2021
- Ownership
- Direct
- Footnotes
- F1
HQY
transaction
Common Stock
Sale
- Transaction value
- $351,249
- Shares
- -5,665
- Change %
- -5.8%
- Price
- $62.00
- Shares after
- 91,387
- Date
- 20 Sep 2021
- Ownership
- Direct
- Footnotes
- F1, F2
HQY
transaction
Common Stock
Sale
- Transaction value
- $21,095
- Shares
- -335
- Change %
- -0.37%
- Price
- $62.97
- Shares after
- 91,052
- Date
- 20 Sep 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HQY
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 20 Sep 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $14.00
- Footnotes
- F1, F3
HQY
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,000
- Date
- 20 Sep 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $25.39
- Footnotes
- F3
HQY
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 19,897
- Date
- 20 Sep 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,897
- Exercise price
- $41.28
- Footnotes
- F3
HQY
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 14,228
- Date
- 20 Sep 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,228
- Exercise price
- $61.72
- Footnotes
- F4
HQY
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,337
- Date
- 20 Sep 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,337
- Exercise price
- $73.61
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Darcy G. Mott is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 5 footnotes
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.53 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
Footnote F3
The option is immediately exercisable.
Footnote F4
The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022.
Footnote F5
The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023.